MDPI

Immuno Template

Write in a clean editor, then format for Immuno in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Immuno format

Immuno is a peer-reviewed journal published by MDPI, covering Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers. Over its lifetime it has published 251 papers, which have received 1,350 citations.

PublisherMDPI
Reference styleNumbered (MDPI)
Numbered — [1], [2] in the text
1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Immuno 2023, 12, 45–58.

Formats any DOI in Immuno style. No sign-up.

Publishes research inImmune Cell Function and Interaction Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers Immune cells in cancer COVID-19 Clinical Research Studies
ISSN2673-5601
Citation impact (2-yr)2.31
h-index19
i10-index44
Article processing charge$1,082
Open accessYes — indexed in DOAJ
Top institutions publishing hereMedical University of Sofia
Journal websitewww.mdpi.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Immuno per year

45
2021
40
2022
23
2023
39
2024
65
2025

Citation impact of Immuno by publication year

329
2021
490
2022
187
2023
192
2024
112
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Immuno

Host–Pathogen Interaction in Leishmaniasis: Immune Response and Vaccination Strategies

Hadida Yasmin, Anureeta Adhikary, Mohammed N. Al‐Ahdal et al. · 9 Mar 2022

Leishmaniasis is a zoonotic and vector-borne infectious disease that is caused by the genus Leishmania belonging to the trypanosomatid family. The protozoan parasite has a digenetic life cycle involving a mammalian host and an insect vector. Leishmaniasisis is a worldwide public health problem falling under the neglected tropical disease category, with over 90 endemic countries,…

The Immunomodulatory Effects of Statins on Macrophages

Alanah Sheridan, Caroline Wheeler‐Jones, Matthew Gage · 8 Apr 2022

Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors used worldwide to manage dyslipidaemia and thus limit the development of atherosclerotic disease and its complications. These atheroprotective drugs are now known to exert pleiotropic actions outside of their cholesterol-lowering activity, including altering immune cell function. Macrophages are phagocytic leukocytes that play critical functional roles in the…

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy

‏Helal F. Hetta, Yasmin N. Ramadan, Ahmad A. Alharbi et al. · 21 Oct 2024

Inflammatory bowel disease (IBD) is a chronic complicated inflammatory gut pathological disorder and is categorized into ulcerative colitis (UC) and Crohn’s disease (CD). Although the cause of IBD is unclear, dysbiosis of the gut microbiota is thought to be a key factor in the disease’s progression. The gut microbiome serves as a metabolic organ and…

Clostridium perfringens-Induced Necrotic Diseases: An Overview

Ying Fu, Tahrir Alenezi, Xiaolun Sun · 7 May 2022

Clostridium perfringens, a prevalent Gram-positive bacterium, causes necrotic diseases associated with abundant life loss and economic burdens of billions of USD. The mechanism of C. perfringens-induced necrotic diseases remains largely unknown, in part, because of the lack of effective animal models and the presence of a large array of exotoxins and diverse disease manifestations from…

Autophagy in Virus Infection: A Race between Host Immune Response and Viral Antagonism

Karan Chawla, G. Mani Subramanian, Tia Rahman et al. · 30 Jan 2022

Virus-infected cells trigger a robust innate immune response and facilitate virus replication. Here, we review the role of autophagy in virus infection, focusing on both pro-viral and anti-viral host responses using a select group of viruses. Autophagy is a cellular degradation pathway operated at the basal level to maintain homeostasis and is induced by external…

Immuno template — frequently asked questions

How do I write a paper in the Immuno format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Immuno template. When you export, DocuGuru compiles the paper into the official MDPI format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Immuno use?
Immuno uses Numbered (MDPI) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Immuno 2023, 12, 45–58.
Do I need to know LaTeX to submit to Immuno?
No. DocuGuru generates the mdpi LaTeX class and compiles the PDF for you in the background, so you get a MDPI-ready Immuno document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Immuno template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Immuno format with correct headings, figures, tables, and numbered citations.
What is Immuno?
Immuno - MDPI Journal. It is a multidisciplinary journal, published by MDPI.
Can I export a submission-ready Immuno PDF?
Yes — DocuGuru produces a PDF built with the official Immuno template (the mdpi class) that is ready to submit to MDPI, together with the matching LaTeX source files.
How much does the Immuno template cost?
You can start writing in the Immuno template for free. Exporting the final submission-ready Immuno PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Immuno template